Mediterranean Diet and the Microbiota Gut Brain Axis in Major Depression
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Mediterranean Diet, Normal hospital diet, dietary coaching, Psychoeducation on depression.
- Who it may be relevant to
- Registry conditions: Depression. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Mediterranean Diet and the Microbiota Gut Brain Axis- Does Diet Interact With the Function of Vagal Nerve in Major Depression?
Overview
The purpose of this study is to assess the efficacy of a Mediterranean diet on the function of the vagal nerve in patients with depression.
Detailed description
After being informed about the study and potential risks, all patients giving written informed consent will be screened for eligibility. Subjects meeting the inclusion criteria will be randomized in a group recieiving a Mediterranean diet (3 mediterranean meals a day) and dietary coaching (1 session per week for 4 weeks) or a group with conventional hospital food and psychoeducation on depression (1 session per week for 4 weeks).
Interventions
- Other Mediterranean Diet
Diet meeting the requirements for mediterranean style (rich in vegetables, fruit, olive oil, fish) (Davis et al., 2015) - Other Normal hospital diet
Normal hospital diet - Other dietary coaching
dietary coaching - Other Psychoeducation on depression
Psychoeducation on depression (50minutes once a week for 4 weeks)
Primary outcome measures
- Change in Vagal function [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
Secondary outcome measures (12)
- Change of C-reactive protein (CRP) [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Interleukine-6 [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Oxytocin [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change of Gut microbiome [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change of Body mass Index [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Hamilton Scale for Depression (HAMD) [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Beck Depression Inventory (BDI) [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Pittsburgh Sleep Quality Inventory (PSQI) [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Adult Attachment Scale [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Wiener Ernährungsprotokoll [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in Mediterranean Diet Score [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
- Change in International Physical Acitivity Questionnaire [Time frame: at study entry, after 7 days, after 4 weeks and after 3 months]
Eligibility criteria
Inclusion criteria
- legally competent persons aged 18-80 years
- diagnosis of depression according to ICD-10 or DSM.
Exclusion criteria
- other neurologic or psychiatric disorders (epilepsy, brain tumor, head injury, head surgery, trauma)
- drug or alcohol dependency
- acute suicidality
- heart disorders, disorders of the circulatory system
- pregnancy and period of breastfeeding
- severe mental disability, dementia (MMST<20)
- autoimmune disorder, severe immunosuppression (Lupus, HIV, multiple sclerosis)
- therapy with antibiotics in the last month
- chronic laxative abuse
- acute infectious diarrhea
- GI surgeries (except appendectomy)
- regular intake of probiotics, antibiotics and food supplements (1 month before and during the study)
- food allergies or other food intolerances which are incompatible with a mediterranean diet
- vegetarians, vegans
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Basic science
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT04772651 · EK 1087 ex 2021